During the past decade, Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gastroenterologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gastroenterologie" #1 collaborator was "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gastroenterologie" are "Breast Cancer" (1 trials), "HER 2 Negative Breast Cancer" (1 trials), "Hormone Receptor Positive Tumor" (1 trials) and "Myeloid Leukemia, Chronic, Chronic-Phase" (1 trials). Many other conditions were trialed in "Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gastroenterologie" in a lesser frequency.

Most popular intervention types in "Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gastroenterologie" are "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine + bevacizumab OR Paclitaxel +/- bevacizumab" (1 trials) and "Ribociclib and aromatase inhibitor or fulvestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gastroenterologie" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gastroenterologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gastroenterologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gastroenterologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".